Ex vivo T-lymphocyte derived cytokine production in sirs patients is influenced by experimental procedures

Shock

Volumn 13, Issue 3, 2000, Pages 169-174

  Muret, Jane ^a   Marie, Christelle ^b   Fitting, Catherine ^b   Payen, Didier ^a   Cavaillon, Jean Marc ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Concanavalin A; Inflammation; Interleukin 10; Interleukin 5; Lipopolysaccharide; Sepsis; Th1 and Th2 cytokines

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CONCANAVALIN A; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN DERIVATIVE; PHYTOHEMAGGLUTININ;

ADULT; AGED; ANESTHESIA; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MONONUCLEAR CELL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA; ANTIBODIES; ANTIGENS, CD3; CASE-CONTROL STUDIES; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0034145859     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200003000-00001     Document Type: Article

References (43)

1. Marchant A, Devière J, Byl B, De Groote D, Vincent J, Goldman M: Interleukin-10 production during septicaemia. Lancet 343:707-708, 1994.
2. Marie C, Cavaillon J-M, Losser M-R: Elevated levels of circulating transforming growth factor-β1 in patients with the sepsis syndrome. Ann Intern Med 125:520-521, 1996.
3. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 121:235-243, 1997.
4. Muñoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991.
5. Marchant A, Alegre M, Hakim A, Piérard G, Marécaux G, Friedman G, De Groote D, Kahn R, Vincent J, Goldman M: Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 15:265-272, 1995.
6. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O: Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 89:1612-1620, 1997.
7. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL: Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91:853-861, 1993.
8. Marie C, Muret J, Fitting C, Losser M-R, Payen D, Cavaillon J-M: Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91:3439-3446, 1998.
9. Wood J, Rodrick M, O'Mahony J, Palder S, Saporoschetz I, D'Eon P, Mannick J: Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 200:311-320, 1984.
10. Rodrick MM, Wood JJ, O'Mahony JB, Davis CF, Grbic JT, Demling RH, Moss NM, Saporoschetz I, Jordan A, D'Eon P: Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin-1 and 2. J Clin Immunol 6:310-318, 1986.
11. Faist E, Mewes A, Baker CC, Strasser T, Alkan, Rieber P, Heberer G: Prostaglandin E2-dependent suppression of interleukin 2 production in patients with major trauma. J Trauma 27:837-848, 1987.
12. Grzelak I, Olszewski WL, Rowinski W: Blood mononuclear cell production of IL-1 and IL-2 following moderate surgical trauma. Eur Surg Res 21:114-122, 1989.
13. Naldini A, Borrelli E, Cesari S, Giomarelli P, Toscano M: In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass. Cytokine 7:165-170, 1995.
14. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B: Distinct mechanism of immunosuppression as a consequence of major surgery. Infect Immunol 65:2283-2291, 1997.
15. Brune IK, Wilke W, Hensler T, Holzmann B, Siewert JR: Downregulation of T helper type I immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparascopic surgery. Am J Surg 177:55-60, 1999.
16. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492, 1995.
17. Zedler S, Bone RC, Baue AE, H DG, Faist E: T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 27:66-72, 1999.
18. Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker C, Ertel W, Heberer G: Alteration of monocyte function following major injury. Arch Surg 123:287-292, 1988.
19. Mitov IG, Kropec A, Benzing A, Just H, Garotta G, Galanos C, Freudenberg M: Differential cytokine production in stimulated blood cultures from intensive care patients with bacterial infections. Infection 25:206-212, 1997.
20. Napolitano LM, Campbell C, Bass BL: Kinetics of splenocyte interleukin-4 production after injury and lethal endotoxin challenge. J Surg Res 67:33-39, 1997.
21. Abraham E, Chang YH: Haemorrhage-induced alteration in function and cytokine production of T cells and T cell subpopulations. Clin Exp Immunol 90:497-502, 1992.
22. Napolitano L, Campbell C: Polymicrobial sepsis following trauma inhibits interleukin-10 secretion and lymphocyte proliferation. J Trauma 39:104-111, 1995.
23. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579-585, 1994.
24. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM: Dominance of T-helper 2-type cytokine after severe injury. Arch Surg 131:1303-1309, 1996.
25. Meert KL, Ofenstein JP, Sarnaik AP: Altered T cell cytokine production following mechanical trauma. Ann Clin Lab Sci 28:283-288, 1998.
26. Takagi K, Suzuki F, Barrow RE, Wolf SE, Hemdon DN: Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 228:106-111, 1998.
27. Ayala A, Lehman DL, Herdon CD, Chaudry IH: Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch Surg 129:1172-1178, 1994.
28. Miller-Graziano CL, De AK, Kodys K: Altered IL-10 levels in trauma patients monocytes and T lymphocytes. J Clin Immunol 15:93-104, 1995.
29. Naldini A, Borrelli E, Carraro F, Giomarelli P, Toscano M. Interleukin-10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of Th-1 type responses. Cytokine 11:74-79, 1998.
30. Sheeran P, Hall GM: Cytokines in anaesthesia. Br J Anaesthesia 78:201-219, 1997.
31. Bencsics A, Elenkov IJ, Vizi ES: Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: Involvement of the sympathetic nervous system. J Neuroimmunol 73:1-6, 1997.
32. Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA: Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg 83:696-700, 1996.
33. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389-393, 1989.
34. Warren HS, Amato SF, Fitting C, Black KB, Loiselle PM, Pasternack MS, Cavaillon J-M: Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 177:89-97, 1993.
35. Baroja M, Ceuppens J: More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods 98:267-270, 1987.
36. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk H: Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J Exp Med 181:1887-1892, 1995.
37. Kleinschmidt S, Wanner GA, Bußmann D, Kremer JP, ZiegentußT, Menger MD, Bauer M: Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline. Shock 9:12-20, 1998.
38. Ertel W, Keel M, Steckholzer U, Ungethüm U, Trentz O: Interleukin-10 attenuates the release of pro-inflammatory cytokines but depresses splenocytes function in murine endotoxemia. Arch Surg 131:51-56, 1996.
39. Faist E, Markewitz A, Fuchs D, Lang S, Zarius S, Schildberg FW, Wachter H, Reichart B: Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg 214:264-274, 1991.
40. Hisatomi K, Isomura T, Kawara T, Yamashita M, Hirano A, Yoshida H, Eriguchi N, Kosuga K, Ohishi K: Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg 98:580-591, 1989.
41. Dehoux M, Philip I, Chollet-Martin S, Boutten A, Hvass U, Desmonts JM, Durand G: Early production of interleukin-10 during normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 110:286-287, 1995.
42. Brandtzaeg P, Osnes L, Øvstebø R, Joø GB, Westwik AB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184:51-60, 1996.
43. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg 128:89-94, 1993.